Literature DB >> 23986522

Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes.

Magdalena Mazagova1, Hendrik Buikema, Azuwerus van Buiten, Marry Duin, Maaike Goris, Maria Sandovici, Robert H Henning, Leo E Deelman.   

Abstract

Growth differentiation factor 15 (GDF15) is emerging as valuable biomarker in cardiovascular disease and diabetic kidney disease. Also, GDF15 represents an early response gene induced after tissue injury and studies performed in GDF15 knockout (KO) mice suggest that GDF15 plays a protective role after injury. In the current study, we investigated the role of GDF15 in the development of diabetic kidney damage in type 1 and type 2 models of diabetes. Renal damage was assessed in GDF15 KO mice and wild-type (WT) mice in streptozotocin type 1 and db/db type 2 diabetic models. Genetic deletion of GDF15 augmented tubular and interstitial damage in both models of diabetes, despite similar diabetic states in KO and WT mice. Increased tubular damage in KO animals was associated with increased glucosuria and polyuria in both type 1 and type 2 models of diabetes. In both models of diabetes, KO mice showed increased interstitial damage as indicated by increased α-smooth muscle actin staining and collagen type 1 expression. In contrast, glomerular damage was similarly elevated in diabetic KO and WT mice. In type 1 diabetes, GDF15 KO mice demonstrated increased expression of inflammatory markers. In type 2 diabetes, elevated levels of plasma creatinine indicated impaired kidney function in KO mice. GDF15 protects the renal interstitium and tubular compartment in experimental type 1 and 2 diabetes without affecting glomerular damage.

Entities:  

Keywords:  GDF15; TGF-β; diabetes

Mesh:

Substances:

Year:  2013        PMID: 23986522     DOI: 10.1152/ajprenal.00387.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  20 in total

1.  Elevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure.

Authors:  F M Verhamme; L J M Seys; E G De Smet; S Provoost; W Janssens; D Elewaut; G F Joos; G G Brusselle; K R Bracke
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

2.  Growth Differentiation Factor-15 and Risk of CKD Progression.

Authors:  Viji Nair; Cassianne Robinson-Cohen; Michelle R Smith; Keith A Bellovich; Zeenat Yousuf Bhat; Maria Bobadilla; Frank Brosius; Ian H de Boer; Laurent Essioux; Ivan Formentini; Crystal A Gadegbeku; Debbie Gipson; Jennifer Hawkins; Jonathan Himmelfarb; Bryan Kestenbaum; Matthias Kretzler; Maria Chiara Magnone; Kalyani Perumal; Susan Steigerwalt; Wenjun Ju; Nisha Bansal
Journal:  J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 10.121

3.  GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.

Authors:  Linda Yang; Chih-Chuan Chang; Zhe Sun; Dennis Madsen; Haisun Zhu; Søren B Padkjær; Xiaoai Wu; Tao Huang; Karin Hultman; Sarah J Paulsen; Jishu Wang; Anne Bugge; Jane Boesen Frantzen; Per Nørgaard; Jacob Fuglsbjerg Jeppesen; Zhiru Yang; Anna Secher; Haibin Chen; Xun Li; Linu Mary John; Bing Shan; Zhenhua He; Xiang Gao; Jing Su; Kristian T Hansen; Wei Yang; Sebastian Beck Jørgensen
Journal:  Nat Med       Date:  2017-08-28       Impact factor: 53.440

4.  Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Authors:  Nisha Bansal; Leila Zelnick; Michael G Shlipak; Amanda Anderson; Robert Christenson; Rajat Deo; Christopher deFilippi; Harold Feldman; James Lash; Jiang He; John Kusek; Bonnie Ky; Stephen Seliger; Elsayed Z Soliman; Alan S Go
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 8.327

Review 5.  GDF15: a potential therapeutic target for type 1 diabetes.

Authors:  Soumyadeep Sarkar; John T Melchior; Hayden R Henry; Farooq Syed; Raghavendra G Mirmira; Ernesto S Nakayasu; Thomas O Metz
Journal:  Expert Opin Ther Targets       Date:  2022-02-09       Impact factor: 6.902

Review 6.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.

Authors:  Jawed Akhtar Siddiqui; Ramesh Pothuraju; Parvez Khan; Gunjan Sharma; Sakthivel Muniyan; Parthasarathy Seshacharyulu; Maneesh Jain; Mohd Wasim Nasser; Surinder Kumar Batra
Journal:  Cytokine Growth Factor Rev       Date:  2021-11-17       Impact factor: 7.638

7.  Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.

Authors:  V W Tsai; H P Zhang; R Manandhar; K K M Lee-Ng; H Lebhar; C P Marquis; Y Husaini; A Sainsbury; D A Brown; S N Breit
Journal:  Int J Obes (Lond)       Date:  2017-12-05       Impact factor: 5.095

Review 8.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

9.  Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease.

Authors:  Maria Dolores Sanchez-Niño; Alberto Ortiz; Maria Vanessa Perez-Gomez; Soledad Pizarro-Sanchez; Carolina Gracia-Iguacel; Santiago Cano; Pablo Cannata-Ortiz; Jinny Sanchez-Rodriguez; Ana Belen Sanz
Journal:  J Nephrol       Date:  2021-04-13       Impact factor: 3.902

10.  Letter: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9).

Authors:  Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2015-02       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.